Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bay

Showing results (191-200 of 253) with videos related to

Pageof 26
Sort By:
Ebiomedicine|August 20, 2015
Matrix Metalloproteinase Mediated Type I Collagen Degradation - An Independent Risk Factor for Mortality in WomenK Dragsbæk, J S Neergaard, H B Hansen, et al.
JIMD Reports|March 20, 2015
Investigating the Robustness and Diagnostic Potential of Extracellular Matrix Remodelling Biomarkers in AlkaptonuriaF Genovese, A S Siebuhr, K Musa, et al.
Scientific Reports|August 4, 2019
Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritisMarkéta Hušáková, Anne-C Bay-Jensen, Šárka Forejtová, et al.
Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology|March 9, 2021
A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritisYunyun Luo, Jonathan Samuels, Svetlana Krasnokutsky, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 21, 2013
D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptorsC Bay-Richter, M J O'Callaghan, N Mathur, et al.
Scientific Reports|August 21, 2020
Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritisMarkéta Hušáková, Anne-C Bay-Jensen, Šárka Forejtová, et al.
Clinical Biochemistry|April 28, 2018
Aggrecanase degradation of type III collagen is associated with clinical knee painA C Bay-Jensen, C F Kjelgaard-Petersen, K K Petersen, et al.
Diagnostic Microbiology and Infectious Disease|December 21, 2019
Fosfomycin resistance mediated by fos genes remains rare among extended-spectrum beta-lactamase-producing Escherichia coli clinical isolates recovered from the urine of patients evaluated at Canadian hospitals (CANWARD, 2007-2017)Andrew Walkty, James A Karlowsky, Melanie R Baxter, et al.
Plastic Surgery (Oakville, Ont.)|November 15, 2024
Risk Factors for Acute Intraoperative Bradycardia in Patients Undergoing Gender-affirming MastectomySarah M Thornton, Ellen C Shaffrey, Caroline C Bay, et al.
Osteoarthritis and Cartilage|March 6, 2021
Does moderate intensity impact exercise and non-impact exercise induce acute changes in collagen biochemical markers related to osteoarthritis? - An exploratory randomized cross-over trialJ J Bjerre-Bastos, H B Nielsen, J R Andersen, et al.
Pageof 26

Showing results (191-200 of 253) with videos related to

Sort By:
Pageof 26
Ebiomedicine|August 20, 2015
Matrix Metalloproteinase Mediated Type I Collagen Degradation - An Independent Risk Factor for Mortality in WomenK Dragsbæk, J S Neergaard, H B Hansen, et al.
JIMD Reports|March 20, 2015
Investigating the Robustness and Diagnostic Potential of Extracellular Matrix Remodelling Biomarkers in AlkaptonuriaF Genovese, A S Siebuhr, K Musa, et al.
Scientific Reports|August 4, 2019
Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritisMarkéta Hušáková, Anne-C Bay-Jensen, Šárka Forejtová, et al.
Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology|March 9, 2021
A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritisYunyun Luo, Jonathan Samuels, Svetlana Krasnokutsky, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 21, 2013
D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptorsC Bay-Richter, M J O'Callaghan, N Mathur, et al.
Scientific Reports|August 21, 2020
Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritisMarkéta Hušáková, Anne-C Bay-Jensen, Šárka Forejtová, et al.
Clinical Biochemistry|April 28, 2018
Aggrecanase degradation of type III collagen is associated with clinical knee painA C Bay-Jensen, C F Kjelgaard-Petersen, K K Petersen, et al.
Diagnostic Microbiology and Infectious Disease|December 21, 2019
Fosfomycin resistance mediated by fos genes remains rare among extended-spectrum beta-lactamase-producing Escherichia coli clinical isolates recovered from the urine of patients evaluated at Canadian hospitals (CANWARD, 2007-2017)Andrew Walkty, James A Karlowsky, Melanie R Baxter, et al.
Plastic Surgery (Oakville, Ont.)|November 15, 2024
Risk Factors for Acute Intraoperative Bradycardia in Patients Undergoing Gender-affirming MastectomySarah M Thornton, Ellen C Shaffrey, Caroline C Bay, et al.
Osteoarthritis and Cartilage|March 6, 2021
Does moderate intensity impact exercise and non-impact exercise induce acute changes in collagen biochemical markers related to osteoarthritis? - An exploratory randomized cross-over trialJ J Bjerre-Bastos, H B Nielsen, J R Andersen, et al.
Pageof 26